0001437749-19-017508.txt : 20190827
0001437749-19-017508.hdr.sgml : 20190827
20190827155105
ACCESSION NUMBER: 0001437749-19-017508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190826
FILED AS OF DATE: 20190827
DATE AS OF CHANGE: 20190827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morton Mawae
CENTRAL INDEX KEY: 0001715607
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14602
FILM NUMBER: 191057229
MAIL ADDRESS:
STREET 1: 7473 MAKA'A STREET
CITY: HONOLULU
STATE: HI
ZIP: 96825
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYANOTECH CORP
CENTRAL INDEX KEY: 0000768408
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 911206026
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 73-4460 QUEEN KAAHUMANU HWY
STREET 2: SUITE 102
CITY: KAILUA KONA
STATE: HI
ZIP: 96740
BUSINESS PHONE: 8083261353
MAIL ADDRESS:
STREET 1: 73-4460 QUEEN KAAHUMANU HWY
STREET 2: SUITE 102
CITY: KAILUA-KONA
STATE: HI
ZIP: 96740
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-08-26
0000768408
CYANOTECH CORP
CYAN
0001715607
Morton Mawae
73-4460 QUEEN KAAHUMANU HWY #102
KAILUA-KONA
HI
96740
1
Former CEO and Director
Common Stock
2019-08-26
4
A
0
5700
0
A
14611
D
Common Stock
2019-08-26
4
D
0
2052
0
D
12559
D
Stock Options
3.3500
Common Stock
75000
75000
D
Stock Options
3.8300
Common Stock
45000
45000
D
Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder.
Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder.
Pursuant to Separation Agreement, all stock options are fully vested as of May 22, 2019.
Pursuant to Separation Agreement, all stock options will expire on December 6, 2019.
/s/Jesse Debban, by Power of Attorney
2019-08-27